Skin serum for menopausal women on weight-loss meds
Part of Genetic & congenital, Skin clinical trials.
This study tests a skin serum to improve facial aging signs like fine lines and dullness. It is for post-menopausal women aged 45-65 who are taking a GLP-1 medication (e.g., Ozempic, Wegovy).
Summary written for real people, not researchers, by Clin2.
Who can take part
- Are a woman aged 45 to 65 who has gone through menopause
- Have mild to moderate signs of facial aging (fine lines, sagging, dull texture)
- Have been on a stable dose of a GLP-1 medication like Ozempic, Rybelsus, or Wegovy for at least 3 months
- Are in good overall health
- Are willing to stop using other skin care products before and during the study and avoid certain cosmetic procedures
- Do not smoke, have keloid scars, or have autoimmune conditions like lupus
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a topical serum to improve visible signs of facial aging in people who are currently taking a GLP-1 medication. If you qualify, you'll use the serum for the study period and see if it helps with fine lines, sagging, and skin texture.
This study tests a treatment called poly-L-lactic acid to improve loose skin on the abdomen. It includes women who have been on a stable dose of GLP-1 medication for at least 6 months, as well as a small group who have never taken these drugs.
This study tests a new injectable collagen product to improve the look of facial wrinkles. It aims to see if the treatment is safe and works well for people aged 35 to 65.
This trial tests a radiofrequency microneedling device called Matrix Pro to lift droopy eyebrows and tighten loose skin under the chin and neck. It may help if you have mild to moderate skin laxity and are willing to avoid other cosmetic treatments during the study.
This study tests whether a hyaluronic acid filler (a common wrinkle-smoothing treatment) can improve skin quality in women who are taking GLP-1 medications for weight or diabetes. It aims to see if the filler can help with common skin changes like loss of firmness and wrinkles.
This study looks at how a biostimulator (a type of injectable treatment that helps your skin produce more collagen) changes your skin. Researchers will use special cameras and scans to see these changes, which may help reduce wrinkles on your cheeks.
Hear when a new Laxity; Skin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.